Zusammenfassung
In 1–2% aller CT-Untersuchungen des Abdomens findet sich eine zystische Läsion des Pankreas als Zufallsbefund. Mehr als zwei Drittel dieser Läsionen sind dysontogenetische Zysten oder Pankreaspseudozysten. An echten zystischen Neoplasien finden sich, zumindest in den Resektionsstatistiken, 30% seröse Zystadenome, 45% muzinös zystische Tumoren und 25% intraduktale papillär muzinöse Neoplasien. Die Diagnose einer zystischen Läsion des Pankreas erfolgt meist bildgebend. Symptomatische Läsionen müssen nach entsprechender Diagnostik einer definitiven Therapie zugeführt werden. Zur Einordnung der Artdiagnose bei symptomlosen Patienten ist die Frage des Ganganschlusses der zystischen Läsion (intraduktal papillär muzinöse Neoplasie [IPMN] und Pankreaspseudozyste), die der Größe (Indikation zur Resektion bei IPMN oder Therapieindikation bei Pseudozyste) und vor allem eine wandständige Knotenbildung, die auf Malignität hinweist, wesentlich. Die diagnostische Punktion einer zystischen Läsion mittels Endosonographie hilft bei der Unterscheidung zwischen benignen, potenziell malignen und malignen zystischen Läsionen. In der durch Punktion gewonnenen Zystenflüssigkeit helfen die Bestimmung von Lipase, CEA, Viskosität und Muzingehalt sowie die zytologische Untersuchung bei der Differenzierung. Differenzialdiagnostik und therapeutische Konsequenz werden anhand eines Algorithmus skizziert, wobei der meisten zystischen Läsionen keiner operativen Therapie bedürfen.
Abstract
On abdominal CT scans asymptomatic cystic lesions of the pancreas are accidentally detected in 1–2% of patients. Congenital cysts and pancreatic pseudocysts account for two thirds of these lesions. Pancreatic pseudocysts are a frequent complication of acute and chronic pancreatitis. Among resected cystic neoplasms serous cystic adenoma accounts for 30%, mucinous cystic neoplasms for 45% and intraductal papillary mucinous neoplasms for 25%. The diagnosis of a cystic pancreatic lesion is usually made by diagnostic imaging. Symptomatic lesions require definitive therapeutic treatment after appropriate diagnostic work-up. In the diagnosis of asymptomatic cystic lesions several factors are important, among them whether the cyst is connected to the pancreatic duct (as in IPMN and pseudocysts), the size of lesion (for treatment indications) and whether nodules form in the wall of the cyst (a sign of potential malignancy). EUS-guided fine needle aspiration of the cyst fluid adds to the discrimination between benign, premalignant and malignant cystic lesions. Measuring lipase activity, CEA, viscosity and mucin as well as cytology can help in differentiating cystic lesions. An algorithm is discussed for the differential diagnosis and for selection of the appropriate treatment for pancreatic cystic lesions, most of which never require surgery.
Literatur
Ban S, Naitoh Y, Mino-Kenudson M et al (2006) Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types. Am J Surg Pathol 30:1561–1569
Bernard P, Scoazec JY, Joubert M et al (2002) Intraductal papillary-mucinous tumors of the pancreas: predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 137:1274–1278
Brugge WR, Lewandrowski K, Lee-Lewandrowski E et al (2004) Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126:1330–1336
Crippa S, Fernandez-Del Castillo C, Salvia R et al (2010) Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol 8:213–219
Jong K de, Nio CY, Hermans JJ et al (2010) High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 8:806–811
Fritz S, Hackert T, Hinz U et al (2011) Role of serum carbohydrate antigen 19–9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg 98:104–110
Huang ES, Gazelle GS, Hur C (2010) Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci 55:852–860
Ikeuchi N, Itoi T, Sofuni A et al (2010) Prognosis of cancer with branch duct type IPMN of the pancreas. World J Gastroenterol 16:1890–1895
Ingkakul T, Sadakari Y, Ienaga J et al (2010) Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg 251:70–75
Ishida M, Egawa S, Aoki T et al (2007) Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Pancreas 35:348–352
Jang JY, Kim SW, Ahn YJ et al (2005) Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 12:124–132
Jang JY, Kim SW, Lee SE et al (2008) Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 15:199–205
Kanno A, Satoh K, Hirota M et al (2010) Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol 45:952–959
Kloppel G, Kosmahl M (2001) Cystic lesions and neoplasms of the pancreas. The features are becoming clearer. Pancreatology 1:648–655
Le Borgne J, Calan L de, Partensky C (1999) Cystadenomas and cystadenocarcinomas of the pancreas: a multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 230:152–161
Lerch MM, Stier A, Wahnschaffe U et al (2009) Pancreatic pseudocysts: observation, endoscopic drainage, or resection? Dtsch Arztebl Int 106:614–621
Manfredi R, Graziani R, Motton M et al (2009) Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 253:106–115
Mino-Kenudson M, Fernandez-del Castillo C, Baba Y et al (2011) Prognosis of invasive intraductal papillary mucinous neoplasm depends on histological and precursor epithelial subtypes. Gut 60:1712–1720
Nagai K, Doi R, Kida A et al (2008) Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg 32:271–280
Niedergethmann M, Grutzmann R, Hildenbrand R et al (2008) Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience. World J Surg 32:2253–2260
Pelaez-Luna M, Chari ST, Smyrk TC et al (2007) Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 102:1759–1764
Rodriguez JR, Salvia R, Crippa S et al (2007) Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133:72–79 (quiz 309–310)
Sadakari Y, Ienaga J, Kobayashi K et al (2010) Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas 39:232–236
Sadakari Y, Ohuchida K, Nakata K et al (2010) Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 147:812–817
Salvia R, Crippa S, Falconi M et al (2007) Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut 56:1086–1090
Salvia R, Partelli S, Crippa S et al (2009) Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg 198:709–714
Sawai Y, Yamao K, Bhatia V et al (2010) Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms. Endoscopy 42:1077–1084
Schmidt CM, White PB, Waters JA et al (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246:644–651
Schnelldorfer T, Sarr MG, Nagorney DM et al (2008) Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 143:639–646
Spinelli KS, Fromwiller TE, Daniel RA et al (2004) Cystic pancreatic neoplasms: observe or operate. Ann Surg 239:651–659
Sugiyama M, Atomi Y (1998) Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 228:685–691
Tanaka M (2011) Controversies in the management of pancreatic IPMN. Nat Rev Gastroenterol Hepatol 8:56–60
Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32
Tanno S, Nakano Y, Sugiyama Y et al (2010) Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10:173–178
Uehara H, Nakaizumi A, Ishikawa O et al (2008) Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57:1561–1565
Weinberg BM, Spiegel BM, Tomlinson JS et al (2010) Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology 138:531–540
Werner JB, Bartosch-Harlid A, Andersson R (2011) Cystic pancreatic lesions: current evidence for diagnosis and treatment. Scand J Gastroenterol 46:773–788
Yamaguchi K, Ohuchida J, Ohtsuka T et al (2002) Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2:484–490
Zhang HM, Yao F, Liu GF et al (2011) The differences in imaging features of malignant and benign branch duct type of Intraductal Papillary Mucinous Tumor. Eur J Radiol 80:744–748
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mayerle, J., Kraft, M., Menges, P. et al. Intraduktal papillär muzinöse Neoplasie: Welche Befunde sprechen für Beobachtung?. Chirurg 83, 123–129 (2012). https://doi.org/10.1007/s00104-011-2183-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-011-2183-8
Schlüsselwörter
- Muzinös zystische Neoplasie
- Intraduktal papillär muzinöse Neoplasie
- Seröses Zystadenom
- Pankreaspseudozyste
- Kongenitale Pankreaszyste